P. Roux‐Lombard

990 total citations
18 papers, 814 citations indexed

About

P. Roux‐Lombard is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, P. Roux‐Lombard has authored 18 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in P. Roux‐Lombard's work include Immune Response and Inflammation (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). P. Roux‐Lombard is often cited by papers focused on Immune Response and Inflammation (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). P. Roux‐Lombard collaborates with scholars based in Switzerland, France and United States. P. Roux‐Lombard's co-authors include T. L. Vischer, J M Dayer, Christine Modoux, Jean‐Michel Dayer, F. Moral, H. Yazici, Nuri Çakır, P A Guerne, Sabrina Pagano and Nicolas Vuilleumier and has published in prestigious journals such as Journal of Internal Medicine, Lara D. Veeken and Clinical & Experimental Immunology.

In The Last Decade

P. Roux‐Lombard

18 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Roux‐Lombard Switzerland 15 410 339 145 111 89 18 814
J.A. Symons United Kingdom 7 339 0.8× 205 0.6× 122 0.8× 185 1.7× 54 0.6× 10 735
Barbara Maria Colombo Italy 17 389 0.9× 331 1.0× 69 0.5× 158 1.4× 52 0.6× 35 979
Tsuyoshi Odai Japan 13 243 0.6× 184 0.5× 168 1.2× 108 1.0× 33 0.4× 29 623
Attila Balog Hungary 20 313 0.8× 275 0.8× 115 0.8× 187 1.7× 105 1.2× 61 967
Edit Gyimesi Hungary 21 424 1.0× 283 0.8× 65 0.4× 123 1.1× 46 0.5× 40 1.1k
Yin Su China 17 485 1.2× 406 1.2× 99 0.7× 243 2.2× 73 0.8× 53 1.0k
J V Bertouch Australia 15 308 0.8× 434 1.3× 54 0.4× 112 1.0× 55 0.6× 29 888
V. Modena Italy 13 182 0.4× 277 0.8× 58 0.4× 111 1.0× 52 0.6× 28 678
Nicola B Nixon United Kingdom 17 179 0.4× 321 0.9× 81 0.6× 235 2.1× 46 0.5× 28 849
K Iwabuchi Japan 15 340 0.8× 108 0.3× 81 0.6× 88 0.8× 46 0.5× 60 768

Countries citing papers authored by P. Roux‐Lombard

Since Specialization
Citations

This map shows the geographic impact of P. Roux‐Lombard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Roux‐Lombard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Roux‐Lombard more than expected).

Fields of papers citing papers by P. Roux‐Lombard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Roux‐Lombard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Roux‐Lombard. The network helps show where P. Roux‐Lombard may publish in the future.

Co-authorship network of co-authors of P. Roux‐Lombard

This figure shows the co-authorship network connecting the top 25 collaborators of P. Roux‐Lombard. A scholar is included among the top collaborators of P. Roux‐Lombard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Roux‐Lombard. P. Roux‐Lombard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pisetsky, David S., Sara E. Trace, Kimberly A. Brownley, et al.. (2014). The expression of cytokines and chemokines in the blood of patients with severe weight loss from anorexia nervosa: An exploratory study. Cytokine. 69(1). 110–115. 24 indexed citations
2.
Pagano, Sabrina, Nathalie Satta, Dirk Werling, et al.. (2012). Anti‐apolipoprotein A‐1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. Journal of Internal Medicine. 272(4). 344–357. 64 indexed citations
3.
Girardin, François, Youssef Daali, Marianne Gex‐Fabry, et al.. (2012). Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection. Journal of Viral Hepatitis. 19(8). 568–573. 18 indexed citations
4.
Mombelli, Andrea, Sabrina Pagano, Catherine Giannopoulou, et al.. (2012). Anti‐apolipoprotein A‐1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis. Journal of Periodontal Research. 48(3). 350–356. 25 indexed citations
5.
Pagano, Sabrina, P. Roux‐Lombard, Philippe Sigaud, et al.. (2011). Autoantibodies against apolipoprotein A‐1 and phosphorylcholine for diagnosis of non‐ST‐segment elevation myocardial infarction. Journal of Internal Medicine. 271(5). 451–462. 31 indexed citations
6.
Butty, Vincent L., P. Roux‐Lombard, Jorge Garbino, Jean‐Michel Dayer, & Bara Ricou. (2004). Anti-inflammatory response after infusion of p55 soluble tumor necrosis factor receptor fusion protein for severe sepsis.. PubMed. 14(1). 15–9. 4 indexed citations
7.
Bas, S., Thomas Perneger, Michael Seitz, et al.. (2000). Association of rheumatoid factors and anti‐filaggrin antibodies with severity of erosions in rheumatoid arthritis. Lara D. Veeken. 39(10). 1082–1088. 55 indexed citations
8.
Chalandon, Yves, Bernadette Mermillod, P Beris, et al.. (1999). Benefit of Prestorage Leukocyte Depletion of Single‐Donor Platelet Concentrates. Vox Sanguinis. 76(1). 27–37. 16 indexed citations
9.
Roux‐Lombard, P.. (1998). The interleukin-1 family.. PubMed. 9(4). 565–76. 61 indexed citations
10.
Çakır, Nuri, F. Moral, P. Roux‐Lombard, et al.. (1997). Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.. PubMed. 24(2). 303–8. 192 indexed citations
11.
Roux‐Lombard, P., et al.. (1997). Levels of cytokine inhibitors: a possible marker of disease activity in childhood dermatomyositis and polymyositis.. PubMed. 15(2). 211–4. 14 indexed citations
12.
Gabay, Cem, Paolo Silacci, Daniela Novick, et al.. (1997). Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.. PubMed. 24(8). 1510–6. 121 indexed citations
13.
Perrier, Stéphane, et al.. (1996). IL-1 receptor antagonist in saliva; characterization in normal saliva and reduced concentration in Sjo¨gren's syndrome (SS). Clinical & Experimental Immunology. 106(2). 237–242. 27 indexed citations
16.
Philippe, C., P. Roux‐Lombard, Bruno Fouqueray, et al.. (1993). Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: regulation by desferrioxamine.. PubMed. 80(2). 300–5. 16 indexed citations
17.
Roux‐Lombard, P., et al.. (1992). Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cells.. PubMed. 19(4). 517–23. 24 indexed citations
18.
Roux‐Lombard, P., Christine Modoux, & Jean‐Michel Dayer. (1989). Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: Influence of GM-CSF. Cytokine. 1(1). 45–51. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026